US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cocrystal Pharma, Inc.

1.57

+0.08005.37%

Volume:8.23K

Turnover:12.36K

Market Cap:15.97M

PE:-0.91

High:1.57

Open:1.33

Low:1.33

Close:1.49

Loading ...

Overview Company News Filings

Cocrystal Pharma’s Norovirus Oral Antiviral Candidate Demonstrates Potent Activity Against the Emerging GII.17 Variants

Cocrystal Pharma to Present at Life Science Innovation Northwest 2025 Conference

COCP: Norovirus Challenge Study Planned for 2025…

Zacks Small Cap Research

BRIEF-Cocrystal Pharma FY Net Income USD -17.504 Million

Cocrystal Pharma Reports 2024 Financial Results and Provides Updates on Its Antiviral Drug-Development Programs

THOMSON REUTERS

Cocrystal Pharma FY Operating Income USD -17.878 Million

THOMSON REUTERS

Cocrystal Pharma Inc expected to post a loss of 53 cents a share - Earnings Preview

Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing

Cocrystal Pharma And 2 Other Promising US Penny Stocks To Watch

Simply Wall St.

Cocrystal Pharma Price Target Maintained With a $7.00/Share by HC Wainwright & Co.

BRIEF-Cocrystal Pharma Reports Phase 1 Results With Oral, Broad-Acting Antiviral Drug CDI-988 For Prophylaxis And Treatment Of Norovirus, Coronaviruses And Other Viral Infections

Cocrystal Pharma reports Phase 1 safety, tolerability results of CDI-988

COCP: Phase 2a Trial of CC-42344 Extended…

Zacks Small Cap Research

Cocrystal Pharma Reports Phase 1 Results With Oral, Broad-Acting Antiviral Drug Cdi-988 for Prophylaxis and Treatment of Norovirus, Coronaviruses and Other Viral Infections

THOMSON REUTERS

Cocrystal Pharma Inc - Plans Human Challenge Study in 2025 for Norovirus

THOMSON REUTERS

Cocrystal Pharma Reports Phase 1 Results with Oral, Broad-Acting Antiviral Drug CDI-988 for Prophylaxis and Treatment of Norovirus, Coronaviruses and Other Viral Infections

Cocrystal Pharma Shares Drop 35% Following Phase 2a Study Extension Announcement

Cocrystal Pharma Shares Fall After Flu-Treatment Study Is Extended

Cocrystal Pharma Extends Phase 2A Influenza Challenge Study; Shares Fall

MT Newswires Live

Cocrystal Pharma to Extend Phase 2a Influenza Challenge Study With Oral PB2 Inhibitor Cc-42344

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/COCP/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"COCP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"COCP\",,,,,undefined,":{"symbol":"COCP","market":"US","secType":"STK","nameCN":"Cocrystal Pharma, Inc.","latestPrice":1.57,"timestamp":1745598911303,"preClose":1.49,"halted":0,"volume":8232,"delay":0,"floatShares":6528407,"shares":10173790,"eps":-1.720463,"marketStatus":"Trading","change":0.08,"latestTime":"04-25 12:41:45 EDT","open":1.33,"high":1.57,"low":1.33,"amount":12363.3625584,"amplitude":0.161074,"askPrice":1.62,"askSize":19,"bidPrice":1.58,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-1.720463,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1745611200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":1.49,"preHourTrading":{"tag":"盘前","latestPrice":1.52,"preClose":1.49,"latestTime":"09:27 EDT","volume":10,"amount":15.2,"timestamp":1745587638958},"postHourTrading":{"tag":"盘后","latestPrice":1.59,"preClose":1.46,"latestTime":"19:58 EDT","volume":266,"amount":422.78,"timestamp":1745539113971},"volumeRatio":0.882016},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"COCP\",,,,,undefined,":{"symbol":"COCP","floatShares":6528407,"roa":"-49.98%","roe":"-97.50%","lyrEps":-1.720463,"volumeRatio":0.882016,"shares":10173790,"dividePrice":0,"high":1.57,"amplitude":0.161074,"preClose":1.49,"low":1.33,"week52Low":1.12,"pbRate":"1.68","week52High":3.26,"institutionHeld":0,"latestPrice":1.57,"committee":0.680672,"eps":-1.720463,"divideRate":0,"volume":8232,"delay":0,"ttmEps":-1.720463,"open":1.33,"prevYearClose":2.02,"prevWeekClose":1.31,"prevMonthClose":1.42,"prevQuarterClose":1.42,"fiveDayClose":1.31,"twentyDayClose":1.43,"sixtyDayClose":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"COCP\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529937996","title":"Cocrystal Pharma’s Norovirus Oral Antiviral Candidate Demonstrates Potent Activity Against the Emerging GII.17 Variants","url":"https://stock-news.laohu8.com/highlight/detail?id=2529937996","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529937996?lang=en_us&edition=fundamental","pubTime":"2025-04-24 20:00","pubTimestamp":1745496000,"startTime":"0","endTime":"0","summary":"Norovirus GII.17 variants have overtaken GII.4 as the most prevalent strain and significantly increased norovirus outbreaks in the U.S. and European countries in 2024-2025. Cocrystal Pharma’s pan-viral protease inhibitor CDI-988 shows superior broad-spectrum antiviral activity against major norovirus variants including GII.4 and GII.17 strains. Pan-Viral Inhibitor CDI-988 CDI-988 is a protease inhibitor specifically designed and developed as a broad-spectrum antiviral inhibitor to a highly conserved region in the active site of 3CL viral proteases. Based on a novel mechanism of action and superior broad-spectrum antiviral activity, CDI-988 is a compelling candidate for advancement as a first-in-class oral treatment for both noroviruses and","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cocrystal-pharma-norovirus-oral-antiviral-120000040.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["COCP","BK4007"],"gpt_icon":0},{"id":"2527042247","title":"Cocrystal Pharma to Present at Life Science Innovation Northwest 2025 Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2527042247","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527042247?lang=en_us&edition=fundamental","pubTime":"2025-04-16 20:00","pubTimestamp":1744804800,"startTime":"0","endTime":"0","summary":"BOTHELL, Wash., April 16, 2025  -- Cocrystal Pharma, Inc.  announces that Sam Lee, President and co-CEO, will present a Company overview at the Life Science Innovation Northwest  2025 Conference on Wednesday, April 23, 2025 at 3:00 p.m. Pacific time. The conference is being held April 23-24 at the Seattle Convention Center.Life Science Innovation Northwest  is the Pacific Northwest’s largest annual life science conference. This event brings together investors, public and private life science organizations, research institutions, scientists, entrepreneurs, and the global health community to discuss and feature some of the most compelling life science breakthroughs of our time. Bringing together over 700 attendees, LSINW features 80+ company and research institution presentations, keynote addresses from industry leaders, engaging panel discussions on emerging trends, a dynamic startup fast pitch showdown, insightful poster presentations, and more - making it the must-attend event for the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cocrystal-pharma-present-life-science-120000093.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","COCP"],"gpt_icon":0},{"id":"2524128771","title":"COCP: Norovirus Challenge Study Planned for 2025…","url":"https://stock-news.laohu8.com/highlight/detail?id=2524128771","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524128771?lang=en_us&edition=fundamental","pubTime":"2025-04-01 22:15","pubTimestamp":1743516900,"startTime":"0","endTime":"0","summary":"On January 8, 2025, Cocrystal Pharma, Inc.  announced results from the Phase 1 trial of CDI-988 for the prophylaxis and treatment of norovirus, coronavirus, and other viral infections. The results showed the drug had a favorable safety and tolerability profile for dosing up to 800 mg per day for 10 consecutive days. The company also announced that an additional cohort that will receive a dose of 1,200 mg and a shorter treatment duration of five consecutive days and we anticipate those results in the second quarter of 2025. In addition, Cocrystal is planning to initiate a human challenge study in norovirus-infected individuals to evaluate CDI-988 as a treatment and prophylaxis later in 2025.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cocp-norovirus-challenge-study-planned-141500542.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4181","BK4218","CDC","BK4007","COCP","PK"],"gpt_icon":0},{"id":"2523945510","title":"BRIEF-Cocrystal Pharma FY Net Income USD -17.504 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2523945510","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523945510?lang=en_us&edition=fundamental","pubTime":"2025-03-31 20:00","pubTimestamp":1743422445,"startTime":"0","endTime":"0","summary":"BRIEF-Cocrystal Pharma FY Net Income USD -17.504 Million\n\n\nMar 31 (Reuters) - Cocrystal Pharma FY operating income USD -17.878 million.\n\nFY basic EPS USD -1.72\nFY operating expenses USD 17.878 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nPLXF33F87:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","COCP"],"gpt_icon":0},{"id":"2523945857","title":"Cocrystal Pharma Reports 2024 Financial Results and Provides Updates on Its Antiviral Drug-Development Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2523945857","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523945857?lang=en_us&edition=fundamental","pubTime":"2025-03-31 20:00","pubTimestamp":1743422401,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nTUA1JCV7V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COCP","BK4007"],"gpt_icon":0},{"id":"2523943428","title":"Cocrystal Pharma FY Operating Income USD -17.878 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2523943428","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523943428?lang=en_us&edition=fundamental","pubTime":"2025-03-31 20:00","pubTimestamp":1743422400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nPLXF33F87:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COCP","BK4007"],"gpt_icon":0},{"id":"2521723314","title":"Cocrystal Pharma Inc  expected to post a loss of 53 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2521723314","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521723314?lang=en_us&edition=fundamental","pubTime":"2025-03-24 20:33","pubTimestamp":1742819587,"startTime":"0","endTime":"0","summary":"Cocrystal Pharma Inc  expected to post a loss of53cents a share - Earnings Preview Cocrystal Pharma Inc COCP.OQ COCP.O is expected to show no change in quarterly revenue when it reports  results on Ma","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nL5N3Q70XP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COCP"],"gpt_icon":0},{"id":"2519806034","title":"Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing","url":"https://stock-news.laohu8.com/highlight/detail?id=2519806034","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519806034?lang=en_us&edition=fundamental","pubTime":"2025-03-14 20:35","pubTimestamp":1741955700,"startTime":"0","endTime":"0","summary":"NEW YORK, March 14, 2025  -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Life Science Virtual Investor Forum, held March 13th are now available for online viewing.The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may downloadinvestor materials from the company’s resource section.Select companies are accepting 1x1 management meeting requests through March 18th.Virtual Investor Conferences  is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance thei","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/life-science-virtual-investor-forum-123500525.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TSYW.SI","QID","NQmain","IZOZF","PDSB","NGENF","MNQmain","NVIW.SI","PSQ","LADX","TNXP","BK4007","HMTXF",".IXIC","AVCNF","SQQQ","FBLG","TQQQ","BK4179","COCP","BK4139","USAW.SI","CGTX","QLD","TELIF","FET","USJW.SI"],"gpt_icon":1},{"id":"2510354551","title":"Cocrystal Pharma And 2 Other Promising US Penny Stocks To Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2510354551","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510354551?lang=en_us&edition=fundamental","pubTime":"2025-02-12 04:11","pubTimestamp":1739304691,"startTime":"0","endTime":"0","summary":"As the U.S. stock market navigates through a landscape marked by tariff discussions and Federal Reserve policy updates, investors are keeping a close eye on how these factors influence broader indices like the Dow Jones, S&P 500, and Nasdaq. Penny stocks may be a throwback term, but the opportunities they represent are far from old news. Typically referring to smaller or newer companies, these stocks present an underappreciated chance for growth at lower price points. When combined with strong balance sheets and solid fundamentals, they can offer upside without many of the risks often associated with this corner of the market.Overview: Cocrystal Pharma, Inc. is a biotechnology company dedicated to discovering and developing antiviral therapeutic treatments for serious and chronic viral diseases, with a market cap of $18.62 million.Operations: Cocrystal Pharma, Inc. currently does not report any revenue segments.Click to explore a detailed breakdown of our findings in Cocrystal Pharma's","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cocrystal-pharma-2-other-promising-201131719.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","BK4209","BK4213","PVL","BK4563","BK4142","COCP","SB","TOUR","BK4021","KNDI","BABB"],"gpt_icon":0},{"id":"2505742400","title":"Cocrystal Pharma Price Target Maintained With a $7.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2505742400","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505742400?lang=en_us&edition=fundamental","pubTime":"2025-01-22 21:05","pubTimestamp":1737551100,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/COCP/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 22, 2025 08:05 ET (13:05 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COCP"],"gpt_icon":0},{"id":"2501228727","title":"BRIEF-Cocrystal Pharma Reports Phase 1 Results With Oral, Broad-Acting Antiviral Drug CDI-988 For Prophylaxis And Treatment Of Norovirus, Coronaviruses And Other Viral Infections","url":"https://stock-news.laohu8.com/highlight/detail?id=2501228727","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501228727?lang=en_us&edition=fundamental","pubTime":"2025-01-08 21:56","pubTimestamp":1736344590,"startTime":"0","endTime":"0","summary":"BRIEF-Cocrystal Pharma Reports Phase 1 Results With Oral, Broad-Acting Antiviral Drug CDI-988 For Prophylaxis And Treatment Of Norovirus, Coronaviruses And Other Viral InfectionsJan 8 (Reuters) - Cocr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250108:nTUA3ZJB96:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COCP","BK4007"],"gpt_icon":0},{"id":"2501724218","title":"Cocrystal Pharma reports Phase 1 safety, tolerability results of CDI-988","url":"https://stock-news.laohu8.com/highlight/detail?id=2501724218","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501724218?lang=en_us&edition=fundamental","pubTime":"2025-01-08 21:15","pubTimestamp":1736342155,"startTime":"0","endTime":"0","summary":"Cocrystal Pharma (COCP) announces safety and tolerability results at dosing up to 800 mg per day for 10 consecutive days from the multiple-ascendin...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cocrystal-pharma-reports-phase-1-safety-tolerability-results-of-cdi-988?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cocrystal-pharma-reports-phase-1-safety-tolerability-results-of-cdi-988?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["COCP","BK4007"],"gpt_icon":0},{"id":"2502709098","title":"COCP: Phase 2a Trial of CC-42344 Extended…","url":"https://stock-news.laohu8.com/highlight/detail?id=2502709098","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502709098?lang=en_us&edition=fundamental","pubTime":"2025-01-08 21:05","pubTimestamp":1736341500,"startTime":"0","endTime":"0","summary":"On December 31, 2024, Cocrystal Pharma, Inc.  announced that the Phase 2a clinical trial of its oral PB2 inhibitor, CC-42344, will be extended due to unexpectedly low infection rates among trial participants that were challenged with a H3N2 influenza strain. The Phase 2a trial initiated in December 2023 and completed enrollment in May 2024 with 78 total participants. It is a single center study being conducted in the U.K. designed to test the safety, tolerability, pharmacokinetics , antiviral activity, and clinical measurements of CC-42344.There are no approved therapies for norovirus infection, which is the most common cause of acute gastroenteritis. According to the Centers for Disease Control , there are an estimated 685 million cases and 200,000 deaths caused by norovirus infection each year worldwide. In the U.S., norovirus","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cocp-phase-2a-trial-cc-130500351.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CDC","BK4098","CC","BK4007","PK","COCP","BK4218","BK4181"],"gpt_icon":0},{"id":"2501219927","title":"Cocrystal Pharma Reports Phase 1 Results With Oral, Broad-Acting Antiviral Drug Cdi-988 for Prophylaxis and Treatment of Norovirus, Coronaviruses and Other Viral Infections","url":"https://stock-news.laohu8.com/highlight/detail?id=2501219927","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501219927?lang=en_us&edition=fundamental","pubTime":"2025-01-08 21:00","pubTimestamp":1736341207,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250108:nTUA3ZJB96:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","COCP"],"gpt_icon":0},{"id":"2501211037","title":"Cocrystal Pharma Inc - Plans Human Challenge Study in 2025 for Norovirus","url":"https://stock-news.laohu8.com/highlight/detail?id=2501211037","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501211037?lang=en_us&edition=fundamental","pubTime":"2025-01-08 21:00","pubTimestamp":1736341207,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250108:nTUA3ZJB96:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COCP","BK4007"],"gpt_icon":0},{"id":"2501072125","title":"Cocrystal Pharma Reports Phase 1 Results with Oral, Broad-Acting Antiviral Drug CDI-988 for Prophylaxis and Treatment of Norovirus, Coronaviruses and Other Viral Infections","url":"https://stock-news.laohu8.com/highlight/detail?id=2501072125","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501072125?lang=en_us&edition=fundamental","pubTime":"2025-01-08 21:00","pubTimestamp":1736341200,"startTime":"0","endTime":"0","summary":"Data show favorable safety and tolerability with dosing up to 800 mg for 10 days. “Norovirus outbreaks are surging across the U.S. as well as on cruise ships with nearly 900 passengers sickened from gastrointestinal disease in December alone,” said Sam Lee, Ph.D., Cocrystal’s President and co-CEO. “There are currently no approved antivirals or vaccines for norovirus and the ability to curtail outbreaks is limited, making norovirus infection a significant unmet need. We are pleased to report positive Phase 1 results with these data demonstrating that CDI-988 had a favorable safety profile and was well-tolerated, supporting further clinical advancement of this potentially first effective norovirus antiviral.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cocrystal-pharma-reports-phase-1-130000476.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["COCP","BK4007","CDC"],"gpt_icon":0},{"id":"2500889644","title":"Cocrystal Pharma Shares Drop 35% Following Phase 2a Study Extension Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=2500889644","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500889644?lang=en_us&edition=fundamental","pubTime":"2025-01-01 03:03","pubTimestamp":1735671819,"startTime":"0","endTime":"0","summary":"Phase 2a human challenge trial for the experimental influenza medication CC-42344 was extended by Cocrystal Pharma . Low infection rates among individuals exposed to the H3N2 virus strain presented difficulties for the research meant to assess the safety, tolerability, and antiviral efficacy of the medicine. This problem has postponed the gathering of significant antiviral data, hence the business asked the UK Medicines and Healthcare Products Regulatory Agency for permission to change a procedure.The news sharply dropped the stock price of Cocrystal Pharma; shares dropped almost 35% and closed at $2.10. Notwithstanding the setback, the business underlined the promise of CC-42444, which aims at a crucial stage in the influenza A virus replication. Early studies reveal a solid safety profile and the experimental medicine has showed great in vitro efficacy against resistant bacteria.Using its unique structure-based drug discovery system, Cocrystal Pharma is developing antiviral therapies","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cocrystal-pharma-shares-drop-35-190339268.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["COCP","BK4007"],"gpt_icon":0},{"id":"2495461866","title":"Cocrystal Pharma Shares Fall After Flu-Treatment Study Is Extended","url":"https://stock-news.laohu8.com/highlight/detail?id=2495461866","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495461866?lang=en_us&edition=fundamental","pubTime":"2024-12-31 22:01","pubTimestamp":1735653660,"startTime":"0","endTime":"0","summary":"Cocrystal Pharma shares dropped after the company said it planned to extend a study of an oral treatment for influenza because of an unexpectedly low rate of infection in participants challenged with a strain of the virus.The Bothell, Wash., biotechnology company's shares were down 25% at $2.43 in premarket trading Tuesday. The stock was up about 89% from the start of the year, as of Monday's market close.Cocrystal said it would extend enrollment in the Phase 2a human challenge study of the CDI-42344 drug candidate for pandemic avian and seasonal influenza A infections because the low rate of infection hindered data analysis.\"The establishment of robust influenza infection in healthy, uninfected study subjects is critical to determine clinical endpoints for evaluating antiviral molecules,\" Co-Chief Executive Sam Lee said.Lee added that the company remained optimistic about the treatment's prospects, and was encouraged by its favorable safety and tolerability profile so far.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","COCP"],"gpt_icon":0},{"id":"2495690053","title":"Cocrystal Pharma Extends Phase 2A Influenza Challenge Study; Shares Fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2495690053","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495690053?lang=en_us&edition=fundamental","pubTime":"2024-12-31 21:54","pubTimestamp":1735653290,"startTime":"0","endTime":"0","summary":"Cocrystal Pharma (COCP) said Tuesday it plans to extend enrollment in a phase 2a influenza challenge study due to low influenza infection among study participants, making virology results uninterpreta","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["COCP","BK4007"],"gpt_icon":0},{"id":"2495925516","title":"Cocrystal Pharma to Extend Phase 2a Influenza Challenge Study With Oral PB2 Inhibitor Cc-42344","url":"https://stock-news.laohu8.com/highlight/detail?id=2495925516","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495925516?lang=en_us&edition=fundamental","pubTime":"2024-12-31 21:00","pubTimestamp":1735650006,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241231:nFWN3NV0DT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COCP","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":30,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/COCP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-31","symbol":"COCP","fiscalQuarterEnding":"2024/12","expectedEps":-0.55,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"pre","actualEps":-0.32},{"market":"US","date":"2024-11-13","symbol":"COCP","fiscalQuarterEnding":"2024/09","expectedEps":-0.57,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"pre","actualEps":-0.49},{"market":"US","date":"2024-08-14","symbol":"COCP","fiscalQuarterEnding":"2024/06","expectedEps":-0.51,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723608000000,"reportTimeType":"pre","actualEps":-0.53},{"market":"US","date":"2024-05-13","symbol":"COCP","fiscalQuarterEnding":"2024/03","expectedEps":-0.54,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715572800000,"reportTimeType":"pre","actualEps":-0.39},{"market":"US","date":"2024-03-28","symbol":"COCP","fiscalQuarterEnding":"2023/12","expectedEps":-0.57,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1711598400000,"reportTimeType":"pre","actualEps":-0.44}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"COCP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"COCP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1616126400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/COCP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"COCP","date":"2025-04-23","current":-0.808544,"percent":0.803761,"low":-15.852314,"twenty":-4.14549,"median":-1.118717,"eighty":-0.815906,"high":-0.381225,"avg":-2.762702,"sd":3.269783,"marketCap":14152759},"quantilePoints":[{"date":"2020-05-01","current":-0.969878,"twenty":-13.357435,"median":-1.678549,"eighty":228.475593,"marketCap":46718059},{"date":"2020-05-08","current":-1.014692,"twenty":-13.248082,"median":-1.668954,"eighty":228.475593,"marketCap":48876683},{"date":"2020-05-15","current":-0.890896,"twenty":-13.089189,"median":-1.660238,"eighty":228.475593,"marketCap":47333319},{"date":"2020-05-22","current":-0.942124,"twenty":-12.904195,"median":-1.656847,"eighty":228.475593,"marketCap":50055062},{"date":"2020-05-29","current":-0.947031,"twenty":-12.788407,"median":-1.64803,"eighty":228.475593,"marketCap":50315765},{"date":"2020-06-05","current":-0.912683,"twenty":-12.738757,"median":-1.639937,"eighty":228.475593,"marketCap":48490842},{"date":"2020-06-12","current":-1.403373,"twenty":-12.573318,"median":-1.623615,"eighty":228.475593,"marketCap":74561187},{"date":"2020-06-19","current":-1.275793,"twenty":-12.307294,"median":-1.617511,"eighty":228.475593,"marketCap":67782899},{"date":"2020-06-26","current":-1.540766,"twenty":-12.075804,"median":-1.617511,"eighty":228.475593,"marketCap":81860885},{"date":"2020-07-02","current":-1.501511,"twenty":-11.435102,"median":-1.591821,"eighty":228.475593,"marketCap":79775258},{"date":"2020-07-10","current":-1.756669,"twenty":-10.488794,"median":-1.583731,"eighty":228.475593,"marketCap":93331837},{"date":"2020-07-17","current":-1.908783,"twenty":-10.096639,"median":-1.583731,"eighty":228.475593,"marketCap":101413646},{"date":"2020-07-24","current":-1.952945,"twenty":-9.765322,"median":-1.583731,"eighty":228.475593,"marketCap":103759976},{"date":"2020-07-31","current":-1.658531,"twenty":-9.277785,"median":-1.583731,"eighty":228.475593,"marketCap":88117770},{"date":"2020-08-07","current":-1.930085,"twenty":-9.125582,"median":-1.583731,"eighty":228.475593,"marketCap":106367009},{"date":"2020-08-14","current":-1.816551,"twenty":-8.999358,"median":-1.583731,"eighty":228.475593,"marketCap":100110129},{"date":"2020-08-21","current":-1.551637,"twenty":-8.999358,"median":-1.611206,"eighty":219.876516,"marketCap":85510732},{"date":"2020-08-28","current":-1.277663,"twenty":-8.999358,"median":-1.611206,"eighty":217.161993,"marketCap":70411994},{"date":"2020-09-04","current":-1.09662,"twenty":-8.999358,"median":-1.611206,"eighty":217.161993,"marketCap":60434746},{"date":"2020-09-11","current":-1.096861,"twenty":-8.999358,"median":-1.611206,"eighty":214.207887,"marketCap":60448031},{"date":"2020-09-18","current":-1.205342,"twenty":-8.999358,"median":-1.611206,"eighty":214.207887,"marketCap":66426406},{"date":"2020-09-25","current":-1.108915,"twenty":-8.999358,"median":-1.611206,"eighty":214.207887,"marketCap":61112295},{"date":"2020-10-02","current":-1.088545,"twenty":-8.999358,"median":-1.611206,"eighty":214.207887,"marketCap":59989689},{"date":"2020-10-09","current":-1.122776,"twenty":-8.999358,"median":-1.611206,"eighty":214.207887,"marketCap":61876198},{"date":"2020-10-16","current":-1.086013,"twenty":-8.999358,"median":-1.611206,"eighty":214.207887,"marketCap":59850194},{"date":"2020-10-23","current":-1.036715,"twenty":-8.999358,"median":-1.611206,"eighty":212.612857,"marketCap":57133355},{"date":"2020-10-30","current":-1.005617,"twenty":-8.999358,"median":-1.611206,"eighty":211.043611,"marketCap":55419554},{"date":"2020-11-06","current":-1.043103,"twenty":-8.999358,"median":-1.611206,"eighty":211.043611,"marketCap":57485414},{"date":"2020-11-13","current":-1.064204,"twenty":-8.999358,"median":-1.611206,"eighty":211.043611,"marketCap":59595396},{"date":"2020-11-20","current":-1.088446,"twenty":-8.999358,"median":-1.611206,"eighty":201.138046,"marketCap":60952953},{"date":"2020-11-27","current":-2.314018,"twenty":-8.999358,"median":-1.617511,"eighty":195.75877,"marketCap":129585021},{"date":"2020-12-04","current":-2.032418,"twenty":-8.999358,"median":-1.617511,"eighty":190.614749,"marketCap":113815410},{"date":"2020-12-11","current":-1.89774,"twenty":-8.999358,"median":-1.623615,"eighty":179.617525,"marketCap":106273427},{"date":"2020-12-18","current":-1.885496,"twenty":-8.999358,"median":-1.638904,"eighty":170.629154,"marketCap":105587793},{"date":"2020-12-24","current":-1.89774,"twenty":-8.999358,"median":-1.647648,"eighty":164.932031,"marketCap":106273427},{"date":"2020-12-31","current":-1.665114,"twenty":-8.999358,"median":-1.65475,"eighty":148.457852,"marketCap":93246361},{"date":"2021-01-08","current":-1.750818,"twenty":-8.999358,"median":-1.658661,"eighty":141.866387,"marketCap":98045804},{"date":"2021-01-15","current":-1.848766,"twenty":-8.999358,"median":-1.663294,"eighty":-0.323292,"marketCap":103530888},{"date":"2021-01-22","current":-2.583375,"twenty":-8.999358,"median":-1.668954,"eighty":-0.345906,"marketCap":144668991},{"date":"2021-01-29","current":-2.105879,"twenty":-8.999358,"median":-1.678549,"eighty":-0.362957,"marketCap":117929224},{"date":"2021-02-05","current":-2.436453,"twenty":-8.999358,"median":-1.678549,"eighty":-0.370474,"marketCap":136441368},{"date":"2021-02-12","current":-2.485427,"twenty":-8.999358,"median":-1.685858,"eighty":-0.380575,"marketCap":139183907},{"date":"2021-02-19","current":-2.362992,"twenty":-8.999358,"median":-1.690757,"eighty":-0.390756,"marketCap":132327560},{"date":"2021-02-26","current":-1.922227,"twenty":-8.999358,"median":-1.702965,"eighty":-0.394019,"marketCap":107644697},{"date":"2021-03-05","current":-1.726331,"twenty":-9.012762,"median":-1.708011,"eighty":-0.398964,"marketCap":96674535},{"date":"2021-03-12","current":-1.93447,"twenty":-9.012762,"median":-1.713344,"eighty":-0.417384,"marketCap":108330332},{"date":"2021-03-19","current":-11.778121,"twenty":-9.090068,"median":-1.721316,"eighty":-0.425301,"marketCap":113635312},{"date":"2021-03-26","current":-10.370673,"twenty":-9.262565,"median":-1.726331,"eighty":-0.431382,"marketCap":100056249},{"date":"2021-04-01","current":-10.592901,"twenty":-9.374401,"median":-1.733316,"eighty":-0.444333,"marketCap":102200311},{"date":"2021-04-09","current":-10.444749,"twenty":-9.925866,"median":-1.740656,"eighty":-0.48054,"marketCap":100770936},{"date":"2021-04-16","current":-8.889148,"twenty":-9.925866,"median":-1.748835,"eighty":-0.509659,"marketCap":85762498},{"date":"2021-04-23","current":-9.370644,"twenty":-9.925866,"median":-1.753802,"eighty":-0.553349,"marketCap":90407971},{"date":"2021-04-30","current":-8.740995,"twenty":-9.925866,"median":-1.759589,"eighty":-0.587693,"marketCap":84333124},{"date":"2021-05-07","current":-13.335277,"twenty":-10.091742,"median":-1.770107,"eighty":-0.738666,"marketCap":128658753},{"date":"2021-05-14","current":-11.415805,"twenty":-10.099088,"median":-1.770107,"eighty":-0.744295,"marketCap":110139689},{"date":"2021-05-21","current":-10.781942,"twenty":-10.099088,"median":-1.770107,"eighty":-0.744295,"marketCap":112089064},{"date":"2021-05-28","current":-10.594429,"twenty":-10.099088,"median":-1.770107,"eighty":-0.744295,"marketCap":110139689},{"date":"2021-06-04","current":-11.438233,"twenty":-10.099088,"median":-1.770107,"eighty":-0.744295,"marketCap":118911874},{"date":"2021-06-11","current":-11.719502,"twenty":-10.099088,"median":-1.770107,"eighty":-0.744295,"marketCap":121835943},{"date":"2021-06-18","current":-12.188282,"twenty":-10.099088,"median":-1.770107,"eighty":-0.744295,"marketCap":126709379},{"date":"2021-06-25","current":-12.657062,"twenty":-10.099088,"median":-1.770107,"eighty":-0.744295,"marketCap":131582815},{"date":"2021-07-02","current":-11.250721,"twenty":-10.099088,"median":-1.770107,"eighty":-0.744295,"marketCap":116962499},{"date":"2021-07-09","current":-11.203843,"twenty":-10.099088,"median":-1.770107,"eighty":-0.744295,"marketCap":116475156},{"date":"2021-07-16","current":-10.406918,"twenty":-10.091742,"median":-1.770107,"eighty":-0.744295,"marketCap":108190315},{"date":"2021-07-23","current":-10.688185,"twenty":-10.091742,"median":-1.770107,"eighty":-0.744295,"marketCap":111114376},{"date":"2021-07-30","current":-10.875697,"twenty":-10.091742,"median":-1.770107,"eighty":-0.744295,"marketCap":113063751},{"date":"2021-08-06","current":-10.12565,"twenty":-10.091742,"median":-1.770107,"eighty":-0.744295,"marketCap":105266253},{"date":"2021-08-13","current":-9.656869,"twenty":-10.019253,"median":-1.770107,"eighty":-0.744295,"marketCap":100392809},{"date":"2021-08-20","current":-9.272349,"twenty":-9.866745,"median":-1.770107,"eighty":-0.744295,"marketCap":99418122},{"date":"2021-08-27","current":-10.545024,"twenty":-9.757588,"median":-1.770107,"eighty":-0.744295,"marketCap":113063751},{"date":"2021-09-03","current":-10.363214,"twenty":-9.757588,"median":-1.770107,"eighty":-0.744295,"marketCap":111114376},{"date":"2021-09-10","current":-9.908687,"twenty":-9.757588,"median":-1.770107,"eighty":-0.744295,"marketCap":106240941},{"date":"2021-09-17","current":-9.545065,"twenty":-9.64851,"median":-1.770107,"eighty":-0.744295,"marketCap":102342192},{"date":"2021-09-24","current":-9.363254,"twenty":-9.602882,"median":-1.770107,"eighty":-0.744295,"marketCap":100392809},{"date":"2021-10-01","current":-9.272349,"twenty":-9.545065,"median":-1.770107,"eighty":-0.744295,"marketCap":99418122},{"date":"2021-10-08","current":-8.636011,"twenty":-9.367688,"median":-1.770107,"eighty":-0.744295,"marketCap":92595312},{"date":"2021-10-15","current":-8.547833,"twenty":-9.333606,"median":-1.770107,"eighty":-0.744295,"marketCap":91649866},{"date":"2021-10-22","current":-8.710554,"twenty":-9.272349,"median":-1.770107,"eighty":-0.744295,"marketCap":93394556},{"date":"2021-10-29","current":-8.110578,"twenty":-9.260106,"median":-1.770107,"eighty":-0.744295,"marketCap":86961620},{"date":"2021-11-05","current":-8.600558,"twenty":-9.171749,"median":-1.770107,"eighty":-0.745161,"marketCap":92215184},{"date":"2021-11-12","current":-8.254209,"twenty":-9.090068,"median":-1.770107,"eighty":-0.745161,"marketCap":88501626},{"date":"2021-11-19","current":-6.664252,"twenty":-8.945494,"median":-1.770107,"eighty":-0.745161,"marketCap":79924371},{"date":"2021-11-26","current":-7.88251,"twenty":-8.908182,"median":-1.770107,"eighty":-0.745161,"marketCap":94534940},{"date":"2021-12-03","current":-5.810903,"twenty":-8.840366,"median":-1.770107,"eighty":-0.745161,"marketCap":69690156},{"date":"2021-12-10","current":-5.851538,"twenty":-8.798268,"median":-1.770107,"eighty":-0.745161,"marketCap":70177499},{"date":"2021-12-17","current":-5.988887,"twenty":-8.660737,"median":-1.770107,"eighty":-0.745161,"marketCap":71824721},{"date":"2021-12-23","current":-5.89705,"twenty":-8.636011,"median":-1.770107,"eighty":-0.745161,"marketCap":70723324},{"date":"2021-12-31","current":-5.282639,"twenty":-8.601301,"median":-1.770107,"eighty":-0.745161,"marketCap":63354689},{"date":"2022-01-07","current":-4.832395,"twenty":-8.551546,"median":-1.770107,"eighty":-0.746027,"marketCap":57954914},{"date":"2022-01-14","current":-4.876282,"twenty":-8.441289,"median":-1.770107,"eighty":-0.746027,"marketCap":58481245},{"date":"2022-01-21","current":-4.307374,"twenty":-8.437358,"median":-1.770107,"eighty":-0.746027,"marketCap":51658338},{"date":"2022-01-28","current":-4.14484,"twenty":-8.3231,"median":-1.770107,"eighty":-0.746027,"marketCap":49709061},{"date":"2022-02-04","current":-4.5195,"twenty":-8.187347,"median":-1.770107,"eighty":-0.746027,"marketCap":54202369},{"date":"2022-02-11","current":-4.509748,"twenty":-8.1073,"median":-1.770107,"eighty":-0.746027,"marketCap":54085406},{"date":"2022-02-18","current":-4.2318,"twenty":-7.87895,"median":-1.770107,"eighty":-0.746027,"marketCap":50751976},{"date":"2022-02-25","current":-4.367523,"twenty":-7.636811,"median":-1.770107,"eighty":-0.746027,"marketCap":52379704},{"date":"2022-03-04","current":-4.146465,"twenty":-7.156757,"median":-1.770107,"eighty":-0.746027,"marketCap":49728555},{"date":"2022-03-11","current":-4.143214,"twenty":-6.788435,"median":-1.770107,"eighty":-0.746027,"marketCap":49689567},{"date":"2022-03-18","current":-4.632468,"twenty":-6.307308,"median":-1.770107,"eighty":-0.746027,"marketCap":55557184},{"date":"2022-03-25","current":-4.067783,"twenty":-5.991813,"median":-1.770107,"eighty":-0.746027,"marketCap":57701496},{"date":"2022-04-01","current":-3.641765,"twenty":-5.818705,"median":-1.770107,"eighty":-0.746027,"marketCap":51658435},{"date":"2022-04-08","current":-3.538696,"twenty":-5.697123,"median":-1.770107,"eighty":-0.746027,"marketCap":50196404},{"date":"2022-04-14","current":-3.676121,"twenty":-5.518362,"median":-1.770107,"eighty":-0.746027,"marketCap":52145779},{"date":"2022-04-22","current":-3.520144,"twenty":-5.42103,"median":-1.770107,"eighty":-0.746027,"marketCap":49933239},{"date":"2022-04-29","current":-3.22949,"twenty":-5.325924,"median":-1.770107,"eighty":-0.746027,"marketCap":45810312},{"date":"2022-05-06","current":-2.923808,"twenty":-5.287882,"median":-1.770107,"eighty":-0.746027,"marketCap":41474221},{"date":"2022-05-13","current":-2.525906,"twenty":-5.283452,"median":-1.770107,"eighty":-0.746027,"marketCap":39543066},{"date":"2022-05-20","current":-2.365897,"twenty":-5.283452,"median":-1.770107,"eighty":-0.746027,"marketCap":37038120},{"date":"2022-05-27","current":-2.618052,"twenty":-5.283452,"median":-1.770107,"eighty":-0.746027,"marketCap":40985611},{"date":"2022-06-03","current":-2.720782,"twenty":-5.283452,"median":-1.770107,"eighty":-0.746027,"marketCap":42593845},{"date":"2022-06-10","current":-2.545207,"twenty":-5.283452,"median":-1.770107,"eighty":-0.746027,"marketCap":39845219},{"date":"2022-06-17","current":-2.4431,"twenty":-5.283452,"median":-1.770107,"eighty":-0.746027,"marketCap":38246732},{"date":"2022-06-24","current":-2.365897,"twenty":-5.284265,"median":-1.770107,"eighty":-0.745161,"marketCap":37038120},{"date":"2022-07-01","current":-2.459288,"twenty":-5.284265,"median":-1.770107,"eighty":-0.745161,"marketCap":38500150},{"date":"2022-07-08","current":-2.60311,"twenty":-5.284265,"median":-1.770107,"eighty":-0.745161,"marketCap":40751686},{"date":"2022-07-15","current":-2.692142,"twenty":-5.284265,"median":-1.770107,"eighty":-0.745161,"marketCap":42145489},{"date":"2022-07-22","current":-2.547075,"twenty":-5.284265,"median":-1.770107,"eighty":-0.745161,"marketCap":39874459},{"date":"2022-07-29","current":-2.499751,"twenty":-5.284265,"median":-1.770107,"eighty":-0.745161,"marketCap":39133600},{"date":"2022-08-05","current":-2.521548,"twenty":-5.284265,"median":-1.770107,"eighty":-0.745161,"marketCap":39474838},{"date":"2022-08-12","current":-2.891376,"twenty":-5.284265,"median":-1.770107,"eighty":-0.745161,"marketCap":45264487},{"date":"2022-08-19","current":-1.131879,"twenty":-5.284265,"median":-1.766483,"eighty":-0.745161,"marketCap":41044193},{"date":"2022-08-26","current":-1.110107,"twenty":-5.284265,"median":-1.756669,"eighty":-0.745161,"marketCap":40254686},{"date":"2022-09-02","current":-1.00716,"twenty":-5.284265,"median":-1.750818,"eighty":-0.745161,"marketCap":36521625},{"date":"2022-09-09","current":-0.968991,"twenty":-5.228721,"median":-1.743495,"eighty":-0.745161,"marketCap":35137566},{"date":"2022-09-16","current":-0.967647,"twenty":-5.13305,"median":-1.739973,"eighty":-0.745161,"marketCap":35088832},{"date":"2022-09-23","current":-0.736756,"twenty":-5.09904,"median":-1.727763,"eighty":-0.74024,"marketCap":26716248},{"date":"2022-09-30","current":-0.782182,"twenty":-5.015848,"median":-1.721316,"eighty":-0.736481,"marketCap":28363474},{"date":"2022-10-07","current":-0.661226,"twenty":-4.934088,"median":-1.717614,"eighty":-0.709858,"marketCap":23977371},{"date":"2022-10-14","current":-0.533102,"twenty":-4.871021,"median":-1.708422,"eighty":-0.608522,"marketCap":19331342},{"date":"2022-10-21","current":-0.499503,"twenty":-4.844354,"median":-1.702965,"eighty":-0.572654,"marketCap":18112980},{"date":"2022-10-28","current":-0.503983,"twenty":-4.837518,"median":-1.692615,"eighty":-0.553005,"marketCap":18275429},{"date":"2022-11-04","current":-0.535342,"twenty":-4.759309,"median":-1.689081,"eighty":-0.549229,"marketCap":19412567},{"date":"2022-11-11","current":-0.678697,"twenty":-4.655621,"median":-1.678549,"eighty":-0.549229,"marketCap":24610911},{"date":"2022-11-18","current":-0.627521,"twenty":-4.629055,"median":-1.678549,"eighty":-0.549229,"marketCap":23858990},{"date":"2022-11-25","current":-0.554703,"twenty":-4.611354,"median":-1.669741,"eighty":-0.549229,"marketCap":21090370},{"date":"2022-12-02","current":-0.586829,"twenty":-4.596503,"median":-1.665114,"eighty":-0.549229,"marketCap":22311820},{"date":"2022-12-09","current":-0.582545,"twenty":-4.592482,"median":-1.658695,"eighty":-0.549229,"marketCap":22148960},{"date":"2022-12-16","current":-0.509727,"twenty":-4.592482,"median":-1.655494,"eighty":-0.543406,"marketCap":19380340},{"date":"2022-12-23","current":-0.421917,"twenty":-4.592482,"median":-1.647648,"eighty":-0.525653,"marketCap":16041710},{"date":"2022-12-30","current":-0.417634,"twenty":-4.592482,"median":-1.638904,"eighty":-0.509727,"marketCap":15878850},{"date":"2023-01-06","current":-0.454043,"twenty":-4.592482,"median":-1.626342,"eighty":-0.498187,"marketCap":17263160},{"date":"2023-01-13","current":-0.458326,"twenty":-4.592482,"median":-1.618166,"eighty":-0.48335,"marketCap":17426020},{"date":"2023-01-20","current":-0.492594,"twenty":-4.592482,"median":-1.617511,"eighty":-0.48335,"marketCap":18728900},{"date":"2023-01-27","current":-0.580404,"twenty":-4.592482,"median":-1.591892,"eighty":-0.48335,"marketCap":22067530},{"date":"2023-02-03","current":-0.674639,"twenty":-4.592482,"median":-1.591653,"eighty":-0.48335,"marketCap":25650450},{"date":"2023-02-10","current":-0.580404,"twenty":-4.592482,"median":-1.583731,"eighty":-0.48335,"marketCap":22067530},{"date":"2023-02-17","current":-0.477602,"twenty":-4.592482,"median":-1.583731,"eighty":-0.480688,"marketCap":18158890},{"date":"2023-02-24","current":-0.406925,"twenty":-4.592482,"median":-1.583517,"eighty":-0.470748,"marketCap":15471700},{"date":"2023-03-03","current":-0.454043,"twenty":-4.592482,"median":-1.583517,"eighty":-0.460896,"marketCap":17263160},{"date":"2023-03-10","current":-0.417334,"twenty":-4.592482,"median":-1.583517,"eighty":-0.450652,"marketCap":15867449},{"date":"2023-03-17","current":-0.396217,"twenty":-4.592482,"median":-1.569527,"eighty":-0.448315,"marketCap":15064550},{"date":"2023-03-24","current":-0.399429,"twenty":-4.564687,"median":-1.562425,"eighty":-0.444619,"marketCap":15186695},{"date":"2023-03-31","current":-0.417246,"twenty":-4.519825,"median":-1.552061,"eighty":-0.438651,"marketCap":16204570},{"date":"2023-04-06","current":-0.406779,"twenty":-4.509911,"median":-1.541119,"eighty":-0.432034,"marketCap":15798064},{"date":"2023-04-14","current":-0.526296,"twenty":-4.398569,"median":-1.526915,"eighty":-0.430228,"marketCap":20439763},{"date":"2023-04-21","current":-0.620848,"twenty":-4.283651,"median":-1.505609,"eighty":-0.430228,"marketCap":24111882},{"date":"2023-04-28","current":-0.654903,"twenty":-4.151991,"median":-1.491697,"eighty":-0.430228,"marketCap":25434475},{"date":"2023-05-05","current":-0.662762,"twenty":-4.089087,"median":-1.477202,"eighty":-0.430228,"marketCap":25739688},{"date":"2023-05-12","current":-0.705671,"twenty":-4.070648,"median":-1.462998,"eighty":-0.432544,"marketCap":27406155},{"date":"2023-05-19","current":-0.587667,"twenty":-4.070648,"median":-1.462998,"eighty":-0.439616,"marketCap":23399717},{"date":"2023-05-26","current":-0.569781,"twenty":-4.070648,"median":-1.462998,"eighty":-0.447562,"marketCap":22687551},{"date":"2023-06-02","current":-0.569781,"twenty":-4.070648,"median":-1.462998,"eighty":-0.449009,"marketCap":22687551},{"date":"2023-06-09","current":-0.674539,"twenty":-4.070648,"median":-1.462998,"eighty":-0.451486,"marketCap":26858805},{"date":"2023-06-16","current":-0.666874,"twenty":-4.070648,"median":-1.462998,"eighty":-0.460896,"marketCap":26553591},{"date":"2023-06-23","current":-0.648989,"twenty":-4.072081,"median":-1.462998,"eighty":-0.470534,"marketCap":25841426},{"date":"2023-06-30","current":-0.628548,"twenty":-4.073513,"median":-1.462998,"eighty":-0.479792,"marketCap":25027523},{"date":"2023-07-07","current":-0.613218,"twenty":-4.074946,"median":-1.466549,"eighty":-0.487594,"marketCap":24417096},{"date":"2023-07-14","current":-0.664319,"twenty":-4.074946,"median":-1.466549,"eighty":-0.496877,"marketCap":26451854},{"date":"2023-07-21","current":-0.697535,"twenty":-4.074946,"median":-1.466549,"eighty":-0.503983,"marketCap":27774446},{"date":"2023-07-28","current":-0.643878,"twenty":-4.074946,"median":-1.466549,"eighty":-0.518294,"marketCap":25637950},{"date":"2023-08-04","current":-0.682205,"twenty":-4.074946,"median":-1.466549,"eighty":-0.526861,"marketCap":27164019},{"date":"2023-08-11","current":-0.753747,"twenty":-4.074946,"median":-1.466549,"eighty":-0.535342,"marketCap":30012680},{"date":"2023-08-18","current":-1.425454,"twenty":-4.074946,"median":-1.480753,"eighty":-0.551021,"marketCap":27876184},{"date":"2023-08-25","current":-1.461871,"twenty":-4.074946,"median":-1.486093,"eighty":-0.554703,"marketCap":28588349},{"date":"2023-09-01","current":-1.560716,"twenty":-4.074946,"median":-1.497084,"eighty":-0.559981,"marketCap":30521370},{"date":"2023-09-08","current":-1.123716,"twenty":-4.074946,"median":-1.497084,"eighty":-0.567553,"marketCap":21975386},{"date":"2023-09-15","current":-1.061287,"twenty":-4.074946,"median":-1.497084,"eighty":-0.569781,"marketCap":20754531},{"date":"2023-09-22","current":-1.030073,"twenty":-4.074946,"median":-1.497084,"eighty":-0.577447,"marketCap":20144104},{"date":"2023-09-29","current":-1.014466,"twenty":-4.074946,"median":-1.497084,"eighty":-0.580404,"marketCap":19838890},{"date":"2023-10-06","current":-1.061287,"twenty":-4.074946,"median":-1.497084,"eighty":-0.586829,"marketCap":20754531},{"date":"2023-10-13","current":-0.978049,"twenty":-4.074946,"median":-1.497084,"eighty":-0.591112,"marketCap":19126725},{"date":"2023-10-20","current":-0.874001,"twenty":-4.074946,"median":-1.497084,"eighty":-0.598008,"marketCap":17091967},{"date":"2023-10-27","current":-0.879204,"twenty":-4.074946,"median":-1.498288,"eighty":-0.60429,"marketCap":17193705},{"date":"2023-11-03","current":-0.926025,"twenty":-4.074946,"median":-1.498288,"eighty":-0.611179,"marketCap":18109346},{"date":"2023-11-10","current":-0.93643,"twenty":-4.074946,"median":-1.498288,"eighty":-0.61571,"marketCap":18312822},{"date":"2023-11-17","current":-0.886346,"twenty":-4.074946,"median":-1.498288,"eighty":-0.619712,"marketCap":15972850},{"date":"2023-11-24","current":-0.824246,"twenty":-4.074946,"median":-1.498288,"eighty":-0.625361,"marketCap":14853733},{"date":"2023-12-01","current":-1.072649,"twenty":-4.074946,"median":-1.498288,"eighty":-0.631103,"marketCap":19330201},{"date":"2023-12-08","current":-1.001515,"twenty":-4.074946,"median":-1.4999,"eighty":-0.637045,"marketCap":18048303},{"date":"2023-12-14","current":-1.016193,"twenty":-4.079822,"median":-1.505609,"eighty":-0.642299,"marketCap":18312822},{"date":"2023-12-22","current":-1.067003,"twenty":-4.087137,"median":-1.505609,"eighty":-0.646797,"marketCap":19228463},{"date":"2023-12-29","current":-0.987966,"twenty":-4.088112,"median":-1.505609,"eighty":-0.649529,"marketCap":17804132},{"date":"2024-01-05","current":-1.010548,"twenty":-4.089087,"median":-1.507151,"eighty":-0.654231,"marketCap":18211084},{"date":"2024-01-12","current":-0.959738,"twenty":-4.089087,"median":-1.507151,"eighty":-0.659769,"marketCap":17295443},{"date":"2024-01-19","current":-0.886346,"twenty":-4.090063,"median":-1.501511,"eighty":-0.660576,"marketCap":15972850},{"date":"2024-01-26","current":-0.897638,"twenty":-4.089087,"median":-1.491551,"eighty":-0.660792,"marketCap":16176326},{"date":"2024-02-02","current":-0.92022,"twenty":-4.089087,"median":-1.480753,"eighty":-0.660792,"marketCap":16583277},{"date":"2024-02-09","current":-0.846828,"twenty":-4.089087,"median":-1.46264,"eighty":-0.660792,"marketCap":15260685},{"date":"2024-02-16","current":-0.86941,"twenty":-4.089087,"median":-1.451384,"eighty":-0.660792,"marketCap":15667636},{"date":"2024-02-23","current":-0.8186,"twenty":-4.089087,"median":-1.439402,"eighty":-0.660792,"marketCap":14751995},{"date":"2024-03-01","current":-0.807309,"twenty":-4.088112,"median":-1.429101,"eighty":-0.661009,"marketCap":14548519},{"date":"2024-03-08","current":-0.829891,"twenty":-4.088112,"median":-1.419929,"eighty":-0.661009,"marketCap":14955471},{"date":"2024-03-15","current":-0.829044,"twenty":-4.088112,"median":-1.403373,"eighty":-0.661009,"marketCap":14940210},{"date":"2024-03-22","current":-0.852473,"twenty":-4.088112,"median":-1.369036,"eighty":-0.661009,"marketCap":15362422},{"date":"2024-03-28","current":-0.846828,"twenty":-4.088112,"median":-1.3397,"eighty":-0.661009,"marketCap":15260685},{"date":"2024-04-05","current":-0.831599,"twenty":-4.089087,"median":-1.30291,"eighty":-0.660792,"marketCap":14955471},{"date":"2024-04-12","current":-0.876856,"twenty":-4.089087,"median":-1.294681,"eighty":-0.660792,"marketCap":15769374},{"date":"2024-04-19","current":-0.845742,"twenty":-4.089087,"median":-1.277663,"eighty":-0.660792,"marketCap":15209816},{"date":"2024-04-26","current":-0.854227,"twenty":-4.088112,"median":-1.273457,"eighty":-0.661009,"marketCap":15362422},{"date":"2024-05-03","current":-0.899484,"twenty":-4.088112,"median":-1.227471,"eighty":-0.661009,"marketCap":16176326},{"date":"2024-05-10","current":-0.989998,"twenty":-4.088112,"median":-1.204981,"eighty":-0.661009,"marketCap":17804132},{"date":"2024-05-17","current":-1.193451,"twenty":-4.088112,"median":-1.192088,"eighty":-0.661009,"marketCap":19991497},{"date":"2024-05-24","current":-1.257223,"twenty":-4.088112,"median":-1.177655,"eighty":-0.661009,"marketCap":21059745},{"date":"2024-05-31","current":-1.433356,"twenty":-4.088112,"median":-1.177655,"eighty":-0.661009,"marketCap":24010144},{"date":"2024-06-07","current":-1.567035,"twenty":-4.088112,"median":-1.177655,"eighty":-0.661009,"marketCap":26249395},{"date":"2024-06-14","current":-1.585255,"twenty":-4.089087,"median":-1.177345,"eighty":-0.660792,"marketCap":26554609},{"date":"2024-06-21","current":-1.548753,"twenty":-4.090063,"median":-1.177036,"eighty":-0.660576,"marketCap":25943164},{"date":"2024-06-28","current":-1.548753,"twenty":-4.102253,"median":-1.175733,"eighty":-0.659955,"marketCap":25943164},{"date":"2024-07-05","current":-1.396915,"twenty":-4.102253,"median":-1.175733,"eighty":-0.659955,"marketCap":23399717},{"date":"2024-07-12","current":-1.330106,"twenty":-4.102253,"median":-1.175733,"eighty":-0.659955,"marketCap":22280600},{"date":"2024-07-15","current":-1.396915,"twenty":-4.102253,"median":-1.175733,"eighty":-0.659955,"marketCap":23399717},{"date":"2024-08-02","current":-1.178267,"twenty":-4.144515,"median":-1.153973,"eighty":-0.656828,"marketCap":19737152},{"date":"2024-08-09","current":-1.026429,"twenty":-4.144515,"median":-1.145075,"eighty":-0.656828,"marketCap":17193705},{"date":"2024-08-16","current":-0.970392,"twenty":-4.144515,"median":-1.127576,"eighty":-0.656828,"marketCap":17397180},{"date":"2024-08-23","current":-1.072538,"twenty":-4.144515,"median":-1.122776,"eighty":-0.656828,"marketCap":19228463},{"date":"2024-08-30","current":-0.959042,"twenty":-4.144515,"median":-1.119642,"eighty":-0.656828,"marketCap":17193705},{"date":"2024-09-06","current":-1.01579,"twenty":-4.144515,"median":-1.114787,"eighty":-0.656828,"marketCap":18211084},{"date":"2024-09-13","current":-0.953367,"twenty":-4.144515,"median":-1.108915,"eighty":-0.656828,"marketCap":17091967},{"date":"2024-09-20","current":-0.998766,"twenty":-4.144515,"median":-1.096861,"eighty":-0.656828,"marketCap":17905870},{"date":"2024-09-27","current":-0.970392,"twenty":-4.144515,"median":-1.08975,"eighty":-0.656828,"marketCap":17397180},{"date":"2024-10-04","current":-0.981741,"twenty":-4.144515,"median":-1.088446,"eighty":-0.656828,"marketCap":17600656},{"date":"2024-10-11","current":-0.993091,"twenty":-4.144515,"median":-1.083888,"eighty":-0.656828,"marketCap":17804132},{"date":"2024-10-18","current":-1.15766,"twenty":-4.144515,"median":-1.086013,"eighty":-0.656828,"marketCap":20754531},{"date":"2024-10-25","current":-1.106587,"twenty":-4.144515,"median":-1.089629,"eighty":-0.656828,"marketCap":19838890},{"date":"2024-10-31","current":-1.02714,"twenty":-4.144515,"median":-1.089629,"eighty":-0.656828,"marketCap":18414559},{"date":"2024-11-08","current":-0.964717,"twenty":-4.14484,"median":-1.089689,"eighty":-0.662762,"marketCap":17295443},{"date":"2024-11-15","current":-1.196788,"twenty":-4.14484,"median":-1.090583,"eighty":-0.665382,"marketCap":22382338},{"date":"2024-11-22","current":-1.169589,"twenty":-4.14484,"median":-1.096861,"eighty":-0.670621,"marketCap":21873648},{"date":"2024-11-29","current":-1.123621,"twenty":-4.14484,"median":-1.107348,"eighty":-0.674539,"marketCap":21013963},{"date":"2024-12-06","current":-1.02271,"twenty":-4.14484,"median":-1.108975,"eighty":-0.679649,"marketCap":19126725},{"date":"2024-12-13","current":-1.01183,"twenty":-4.14484,"median":-1.108975,"eighty":-0.687315,"marketCap":18923249},{"date":"2024-12-20","current":-1.142389,"twenty":-4.14484,"median":-1.110783,"eighty":-0.697513,"marketCap":21364959},{"date":"2024-12-27","current":-1.349107,"twenty":-4.14484,"median":-1.115045,"eighty":-0.705671,"marketCap":25230999},{"date":"2025-01-03","current":-1.262068,"twenty":-4.14484,"median":-1.118187,"eighty":-0.725736,"marketCap":23603192},{"date":"2025-01-10","current":-1.309395,"twenty":-4.145165,"median":-1.120629,"eighty":-0.741734,"marketCap":24488312},{"date":"2025-01-17","current":-1.093429,"twenty":-4.145165,"median":-1.122656,"eighty":-0.761253,"marketCap":20449317},{"date":"2025-01-24","current":-1.133685,"twenty":-4.145165,"median":-1.122776,"eighty":-0.774604,"marketCap":21202178},{"date":"2025-01-31","current":-1.083638,"twenty":-4.145165,"median":-1.122776,"eighty":-0.784117,"marketCap":20266189},{"date":"2025-02-07","current":-1.02815,"twenty":-4.145165,"median":-1.122776,"eighty":-0.795815,"marketCap":19228463},{"date":"2025-02-14","current":-1.01183,"twenty":-4.145165,"median":-1.123621,"eighty":-0.808638,"marketCap":18923249},{"date":"2025-02-21","current":-1.06623,"twenty":-4.145165,"median":-1.123621,"eighty":-0.817765,"marketCap":19940628},{"date":"2025-02-28","current":-0.941111,"twenty":-4.145165,"median":-1.122776,"eighty":-0.818532,"marketCap":17600656},{"date":"2025-03-07","current":-0.957431,"twenty":-4.14549,"median":-1.120629,"eighty":-0.818465,"marketCap":17905870},{"date":"2025-03-14","current":-0.908471,"twenty":-4.14549,"median":-1.11932,"eighty":-0.818465,"marketCap":16990229},{"date":"2025-03-21","current":-0.843192,"twenty":-4.14549,"median":-1.11932,"eighty":-0.820967,"marketCap":15769374},{"date":"2025-03-28","current":-0.777912,"twenty":-4.14549,"median":-1.11932,"eighty":-0.820967,"marketCap":14548519},{"date":"2025-04-04","current":-0.819529,"twenty":-4.14549,"median":-1.11932,"eighty":-0.824246,"marketCap":14345043},{"date":"2025-04-11","current":-0.712003,"twenty":-4.145165,"median":-1.118997,"eighty":-0.821195,"marketCap":12462892},{"date":"2025-04-17","current":-0.761407,"twenty":-4.145165,"median":-1.118437,"eighty":-0.81871,"marketCap":13327664},{"date":"2025-04-23","current":-0.808544,"twenty":-4.14549,"median":-1.118717,"eighty":-0.815906,"marketCap":14152759}],"updateTime":1745556698522}}}